Home > Insider Trading > Filing (0001738048-20-000002)

Filing Details

Accession Number:: 0001738048-20-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-28 18:34:43
Reporting Period:: 2020-05-26

Accepted Time:: 2020-05-28 18:34:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326190	Altimmune Inc.	ALT	Pharmaceutical Preparations (2834)	202726770

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1602263	Vhcp Management Ii, Llc	C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018	No	No	Yes	No
1602264	Venrock Healthcare Capital Partners Ii, L.p.	C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018	No	No	Yes	No
1615979	Y Bong Koh	C/O Venrock 7 Bryant Park 23Rd Floor New York NY 10018	No	No	Yes	No
1615983	Vhcp Co-Investment Holdings Ii, Llc	C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018	No	No	Yes	No
1698082	P Nimish Shah	C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018	No	No	Yes	No
1738048	Venrock Healthcare Capital Partners Iii, L.p.	C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018	No	No	Yes	No
1738053	Vhcp Management Iii, Llc	C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018	No	No	Yes	No
1750761	Vhcp Co-Investment Holdings Iii, Llc	C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-26	309,453	$8.79	2,005,817	No	4	P	Indirect	By Funds
Common Stock	Acquisiton	2020-05-26	390,547	$9.78	2,396,364	No	4	P	Indirect	By Funds
Common Stock	Acquisiton	2020-05-27	125,162	$7.23	2,521,526	No	4	P	Indirect	By Funds
Common Stock	Acquisiton	2020-05-27	277,000	$7.92	2,798,526	No	4	P	Indirect	By Funds
Common Stock	Acquisiton	2020-05-28	27,763	$7.79	2,826,289	No	4	P	Indirect	By Funds
Common Stock	Acquisiton	2020-05-28	173,711	$8.87	3,000,000	No	4	P	Indirect	By Funds

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Funds
No	4	P	Indirect	By Funds
No	4	P	Indirect	By Funds
No	4	P	Indirect	By Funds
No	4	P	Indirect	By Funds
No	4	P	Indirect	By Funds

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.40 to $9.39, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (4), (6), (8), (10) and (12) to this Form 4.
Represents (a) 1,146,325 shares of common stock held by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (b) 114,532 shares of common stock held by VHCP Co-Investment Holdings III, LLC ("VHCP III Co"), (c) 530,137 shares of common stock held by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), and (d) 214,823 shares of common stock held by VHCP Co-Investment Holdings II, LLC ("VHCP II Co").
VHCP Management III, LLC ("VHCPM III") is the sole general partner of VHCP III and the sole manager of VHCP III Co. VHCP Management II, LLC ("VHCPM II") is the sole general partner of VHCP II and the sole manager of VHCP II Co. Dr. Bong Koh and Nimish Shah are the voting members of VHCPM III and VHCPM II. Dr. Koh, Mr. Shah, VHCPM III and VHCPM II disclaim beneficial ownership over all shares held by VHCP III, VHCP III Co, VHCP II and VHCP II Co, except to the extent of their respective indirect pecuniary interests therein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.40 to $10.00, inclusive.
Represents (a) 1,369,523 shares of common stock held by VHCP III, (b) 136,832 shares of common stock held by VHCP III Co, (c) 633,359 shares of common stock held by VHCP II, and (d) 256,650 shares of common stock held by VHCP II Co.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.63 to $7.62, inclusive.
Represents (a) 1,441,054 shares of common stock held by VHCP III, (b) 143,978 shares of common stock held by VHCP III Co, (c) 666,439 shares of common stock held by VHCP II, and (d) 270,055 shares of common stock held by VHCP II Co.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.63 to $8.05, inclusive.
Represents (a) 1,599,360 shares of common stock held by VHCP III, (b) 159,795 shares of common stock held by VHCP III Co, (c) 739,650 shares of common stock held by VHCP II, and (d) 299,721 shares of common stock held by VHCP II Co.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.61 to $8.60, inclusive.
Represents (a) 1,615,227 shares of common stock held by VHCP III, (b) 161,380 shares of common stock held by VHCP III Co, (c) 746,988 shares of common stock held by VHCP II, and (d) 302,694 shares of common stock held by VHCP II Co.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.61 to $9.00, inclusive.
Represents (a) 1,714,502 shares of common stock held by VHCP III, (b) 171,299 shares of common stock held by VHCP III Co, (c) 792,900 shares of common stock held by VHCP II, and (d) 321,299 shares of common stock held by VHCP II Co.